Concentra Biosciences To Acquire CARGO Therapeutics For $4.379 Cash Per Share Plus Contingent Value Right, Deal Expected To Close August 2025

Concentra will acquire CARGO for $4.379 in cash per share of CARGO common stock, par value $0.001 per share ("CARGO Common Stock"), plus one non-transferable contingent value right ("CVR"), which represents the right to receive:

 (i) 100% of the closing net cash of CARGO in excess of $217.5 million; and 

(ii) 80% of any net proceeds received within two years following closing from any disposition of certain of CARGO's product candidates that occurs within two years following closing, each pursuant to a contingent value rights agreement